Effect of caffeine on myocardial perfusion imaging using single photon emission computed tomography during adenosine pharmacologic stress

American Journal of Therapeutics

Volumn 15, Issue 5, 2008, Pages 431-434

  Kovacs, Daniela ^a   Pivonka, Robert ^b   Khosla, Pam G ^a   Khosla, Sandeep ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

Adenosine; Caffeine; Dipyridamole; Nuclear stress test

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR; CAFFEINE; CYCLIC AMP; DIPYRIDAMOLE; PARAXANTHINE; PHOSPHODIESTERASE; THEOBROMINE; THEOPHYLLINE; CENTRAL STIMULANT AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; THALLIUM; VASODILATOR AGENT;

BLOOD LEVEL; CHEMICAL STRUCTURE; HALF LIFE TIME; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEMODYNAMICS; HUMAN; HYPEREMIA; LIVER METABOLISM; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; URINARY EXCRETION; VASODILATATION; CORONARY ARTERY BLOOD FLOW; EXERCISE TEST; HEART; METABOLISM; PATHOPHYSIOLOGY; SCINTISCANNING;

ADENOSINE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CORONARY CIRCULATION; DIPYRIDAMOLE; EXERCISE TEST; HEART; HUMANS; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 55249115375     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31815aec1b     Document Type: Review

References (26)

1. Zoghbi GJ, Htay T, Aqel RA, et al. Effect of caffeine on ischemia detection by adenosine single-photon emission computer tomography perfusion imaging. JACC. 2006;47:2266-2302.
2. Aqel RA, Zoghbi GJ, Trimm JR, et al. Effect of caffeine administered intravenously on intracoronary-administered adenosine-induced coronary hemodynamics in patients with coronary artery disease. Am J Cardiol. 2004;93:343-346.
3. Lapeyre AC, Goraya TY, Gibbons RJ, et al. The impact of caffeine on vasodilator stress perfusion studies. J Nucl Cardiol. 2004;11:506-511.
4. Lovett R. Coffee: the demon drink. New Sci. 2005;2518:38-11.
5. Nathanson JA. Caffeine and related methylxanthine: possible naturally occurring pesticides. Science. 1984;226:184-187.
6. Nehlig A, Daval JL, Debry G, et al. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic, and psychostimulant effects. Brain Res Rev. 1992;17:139-170.
7. Newton R, Broughton LJ, Lind MJ, et al. Plasma and salivary pharmacokinetics of caffeine in man. Eur J Clin Pharmacol. 1981;21:45-52.
8. Meyer, FP, Canzler E, Giers H, et al. Time course of inhibition of caffeine elimination in response to the oral depot contraceptive agent Deposiston: hormonal contraceptives and caffeine elimination. Zentralbl Gynakol. 1991;113:297-302.
9. Ortweiler W, Simon HU, Splinter FK, et al. Determination of caffeine and metamizole elimination in pregnancy and after delivery as an in vivo method for characterization of various cytochrome p-450 dependent biotransformation reactions. Biomed Biochim Acta. 1985;44:1189-1199.
10. Springhouse, ed. Physician's Drug Handbook. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
11. Gilbert RM, Spiller GA, eds. The Methylxanthine Beverages and Foods: Chemistry, Consumption and Health Effects. New York: Allan R Liss; 1984:185-213.
12. Scholz H. Inotropic drugs and their mechanisms of action. J Am Coll Cardiol. 1984;4:389-397.
13. Wennmalm A, Wennmalm M. Coffee, catecholamine and cardiac arrhythmia. Clin Physiol. 1989;9:201.
14. Konishi M, Kurihara S. Effects of caffeine on intracellular calcium concentrations in frog skeletal muscle fibers. J Physiol. 1987;383:169-283.
15. Hess P, Wier WG. Excitation-contraction coupling in cardiac Purkinje fibers: effects of caffeine on the intracellular [Ca2+] transient, membrane currents, and contraction. J Gen Physiol. 1984;83:417-433.
16. Eisner DA, Valdeolmillos M. The mechanism of the increase of tonic tension produced by caffeine in sheep cardiac Purkinje fibres. J Physiol. 1985;364:313-326.
17. Smits P, Schoutern J, Thien T, et al. Cardiovascular effects of two xanthines and the relation with adenosine antagonism. Clin Pharmacol Ther. 1989;45:593-599.
18. Smits P. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation. 1995;92:2135-2141.
19. Meuwissen M, Siebes M, Chamuleau SM, et al. Hyperemic stenosis resistance index for evaluation of functional lesion severity. Circulation. 2002;106:4412-4416.
20. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA Task Force. ACC/AHA practice guidelines. Washington, DC: American College of Cardiology; 2002:23.
21. Bottcher M, Czernin J, Sun KT, et al. Effect of caffeine on myocardial blood flow at rest and during pharmacologic dilatation. J Nucl Med. 1995;36:2016-2021.
22. Kubo S, Tadamura E, Toyoda H, et al. Effect of caffeine on myocardial hyperemic flow induced by adenosine triphosphate and dipyridamole. J Nucl Med. 2005;45:730-738.
23. Smits P, Aengevaeren WR, Corstens FH, et al. Caffeine reduced dipyridamole-induced myocardial ischemia. J Nucl Med. 1989;30:1723-1726.
24. Smits P, Corstens FH, Aengevaeren WR, et al. False negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion. J Nucl Med. 1991;32;1538-1541.
25. Jacobson AF, Cerqueira MD, Raisys V, et al. Serum caffeine levels after 24 hours of caffeine abstention: observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine. Eur J Nucl Med. 1994;21:23-26.
26. FitzGerald GA. Dipyridamole. N Engl J Med. 1987;316:1247-1257.